Aprea Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$14,286,756 and profit margin reached -2450%. Total operating expenses were $16,048,142.
Profit Margin
| 2017 | 0 | -15.19M | |
|---|---|---|---|
| 2018 | 0 | -15.52M | |
| 2019 | 0 | -26.40M | |
| 2020 | 0 | -53.91M | |
| 2021 | 0 | -36.53M | |
| 2022 | 0 | -224.87M | |
| 2023 | 583.23K | -14.28M | -2449.59% |
APRE Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 583.23K | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 7.05K | 186.44K | 271.67K | 229.61K | 170.25K | 0 | 7.93K |
Gross profit | 576.17K | -186.44K | -271.67K | -229.61K | -170.25K | 0 | -7.93K |
Operating exp. | |||||||
Research and development | 7.62M | 16.40M | 23.89M | 37.87M | 20.95M | 14.19M | 13.39M |
Selling and marketing | -7.05K | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 16.04M | 37.37M | 37.44M | 52.81M | 29.54M | 16.48M | 15.85M |
Operating income | -15.47M | 38.18M | -38.03M | -52.15M | -31.04M | -16.48M | -15.85M |
Other income (expenses), net | 1.18M | -150.84M | 908.12K | -667.6K | 2.98M | 961.31K | 662.12K |
Income before tax | -14.28M | -112.66M | -37.12M | -53.47M | -28.05M | -15.52M | -15.19M |
Income tax expense | 0 | 112.21M | -590.72K | 437.99K | -1.65M | 961.31K | -662.12K |
Net income | -14.28M | -224.87M | -36.53M | -53.91M | -26.40M | -15.52M | -15.19M |
Earnings per share | |||||||
Basic EPS | -3.95 | -2.71K | -34.33 | -51.02 | -87.98 | -22.06 | -21.58 |
Diluted EPS | -3.95 | -2.71K | -34.33 | -51.02 | -87.98 | -22.06 | -21.58 |
| Data source | Data source | Data source | Data source | Data source |